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Introduction: Leishmaniasis is a neglected tropical disease caused by vector-borne protozoa of
the genus Leishmania. Cutaneous and mucocutaneous forms result in disfiguration or
mutilation, whilst visceral leishmaniasis (VL) affects multiple organs and is fatal if untreated.
Notably, Leishmania are capable of establishing a chronic infection, which may reactivate years
after initial infection when the host becomes immune-suppressed.
Case Presentation: A 24-year-old human immunodeficiency virus (HIV)-positive male
presented for excision of anal condylomas. At the time of his current condyloma excision, the
patient had no additional symptoms or cutaneous findings, but was noted to have been only
intermittently compliant with his antiretroviral therapy. Microscopic examination of the
haematoxylin and eosin-stained anal condyloma tissue revealed koilocytic change, ulceration
and brisk histiocytic inflammation containing numerous small intracellular bodies suggestive of
Leishmania amastigotes. A bone marrow biopsy was performed and demonstrated similar
intracellular forms. Anal condyloma tissue and bone marrow aspirate were sent to the Centers
for Disease Control and Prevention’s Parasitic Diseases Branch for confirmation of Leishmania
and speciation. Specific immunohistochemical staining for Leishmania in the tissue section was
positive and the species was confirmed as Leishmania donovani by PCR. Subsequently, the
patient resumed highly active antiretroviral therapy and received anti-Leishmania therapy.
Conclusion: Whilst the presentation of VL in HIV-positive patients is often similar to those
without HIV, here we describe an unusual initial presentation of leishmaniasis in an HIV-positive
patient where the parasite was found in an anal condyloma. VL is a critical diagnosis that
should be considered and pursued when leishmaniasis is encountered in seemingly illogical
clinical settings.
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Introduction
Leishmaniasis is not commonly encountered in the USA;
however, the parasite is endemic in tropical and subtropi-
cal regions, and it is estimated that 200 million people
worldwide are at risk of acquiring the infection. The para-
site is transmitted through the bite of female phlebotomine
sandflies; infectious promastigotes are injected into the
skin and are subsequently taken up by professional phago-
cytic cells. Promastigotes next undergo a developmental
switch to the ovoid, non-flagellated amastigotes inside
the macrophages. The parasite multiplies as an amastigote
in macrophages and other cell types, and is subsequently
taken up by a sandfly blood meal. In the sandfly, the amas-
tigotes revert to promastigotes, multiply in the insect
midgut and migrate to the proboscis to infect the mamma-
lian host during the next blood meal.
The genus Leishmania contains 30 species, 21 of which
infect mammals, including humans. The signs and symp-
toms of leishmaniasis vary based upon the infecting species
and the host immune status. Infection may result in
cutaneous, or mucocutaneous disease which is most
likely to be encountered in dermatopathology specimens,
or in visceral disease. Cutaneous disease is most commonly
associated with a focal ulcers with underlying infection
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directly at the sandfly bite site, which often heals without
intervention. Mucocutaneous disease describes spread to
the mucosa; mucosal lesions fail to heal spontaneously
and secondary bacterial infections may be fatal. Visceral
leishmaniasis (VL) may be asymptomatic to severe, and
frequently presents with fever, malaise, anorexia, hepato-
megaly, splenomegaly and lymphadenopathy. Due to the
variety of signs and symptoms, leishmaniasis may be mis-
taken for other diseases, especially outside of endemic
areas. We present a case of VL which was first identified
in an anal condyloma. This location is very unusual and
has not been previously described in the literature.
Case report
The patient is a 24-year-old human immunodeficiency virus
(HIV)-positive male from Nicaragua who presented for exci-
sion of condylomas on his anal mucosa. He was diagnosed
with HIV/AIDS *3 years earlier and was started on antire-
troviral therapy at that time. At the time of his diagnosis
with HIV/AIDS, a peri-rectal skin tag was also noted, but
no other symptoms or cutaneous findings were observed.
At 1 month prior to his excision of his condyloma, the
patient had an HIV viral load of 65 copies ml21 and CD4
T cell count of 144 cells ml21. At the time of the procedure
the patient had no additional health concerns, cutaneous
findings or symptoms, but he was noted to have been only
intermittently compliant with his antiretroviral therapy due
to intolerance of side-effects and lack of medical insurance.
Investigations
Anal condyloma tissue was submitted for histopathology.
Microscopic examination of the haematoxylin and eosin-
stained anal condyloma tissue revealed koilocytic change,
ulceration and brisk histiocytic inflammation containing
numerous small intracellular bodies with kinetoplasts, sug-
gestive of Leishmania amastigotes (cutaneous herpesvirus
cytopathic effect was also present) (Fig. 1a, b). Grocott–
Gomori methenamine silver (Fig. 1c), Periodic Acid–
Schiff, mucicarmine and Fontana–Masson stains were
negative (not shown), which indicated the intracellular
objects were not fungal in origin. The patient also had a
few papillary lesions on his back, which were biopsied
and also contained forms consistent with Leishmania
species amastigotes. Given the unusual anatomical location
(i.e. anal mucosa) for a disease transmitted by an insect
vector coupled with the patient’s previous residence in
Central America, concerns for VL arose. The patient had
lived in the USA for the previous 6 years and had no
travel history to areas endemic for Leishmania since leaving
Nicaragua. A bone marrow biopsy was performed and
demonstrated similar intracellular forms by Giemsa stain
(Fig. 1d), confirming that the patient did have VL.
The condyloma tissue and bone marrow aspirate were sent
to the Centers for Disease Control and Prevention (CDC)’s
Parasitic Diseases Branch for confirmation of Leishmania
infection and speciation. Specific immunohistochemical
staining of the tissue section was positive for Leishmania
species. Leishmania reverse transcription PCR was positive,
and Leishmania PCR and DNA sequencing identified the
isolate as Leishmania donovani. Culture isoenzyme results
also matched L. donovani.
Treatment
Accordingly, the patient resumed antiretroviral therapy
and received anti-Leishmania therapy (intravenous Pentos-
tam) in coordination with the CDC. The lesions on the
patient’s back diminished in size and a second bone
marrow biopsy was negative by microscopy, but did
grow parasites upon culture.
Outcome and follow-up
The patient has completed anti-Leishmania treatment and
is stable on antiretroviral therapy.
Discussion
Anal and rectal condylomas are caused by human papilloma
virus (HPV), a sexually transmitted infection. Due to shared
risk factors, HIV and HPV co-infections are common.
Notably, HIV-positive individuals are more likely to develop
symptomatic HPV infection. Whilst the disease severity cor-
responds to the level of immunosuppression, antiretroviral
therapy has not reduced the incidence of HPV-associated
carcinomas (Palefsky, 2009). The bivalent vaccine (Cervarix)
offers protection against high-risk HPV genotypes (HPV16
and 18) associated with cancer, and the quadrivalent vaccine
(Gardasil) offers protection against the same high-risk HPV
genotypes and a few prevalent strains associated with genital
warts (HPV6 and 11) (Dochez et al., 2014). However, these
vaccines do not provide protection against the numerous
other strains of HPV and patients should be instructed on
the necessity of safe sex practices to prevent infection.
The incidence of HIV and Leishmania co-infection is on
the rise. Whilst HIV is more prevalent in urban regions
and Leishmania in rural regions, increased urbanization
and travel is presumed to contribute to the rate of co-
infection (Saporito et al., 2013). HIV-positive individuals,
especially those with CD4 T-cell counts v200 cells ml21,
have a much greater chance of developing VL (Jarvis &
Lockwood, 2013). HIV-positive patients with VL typically
have similar signs as HIV-negative VL patients (Jarvis &
Lockwood, 2013; Saporito et al., 2013).
Cutaneous dissemination of VL may present as a pigmen-
ted or erythematous papule, lesion, rash or nodule (Balk-
hair & Ben Abid, 2008; Calza et al., 2004; Gonza´lez-Beato
et al., 2000; Santos-Oliveira et al., 2011). As the parasites
replicate in macrophages, atypical cutaneous manifes-
tations of VL may occur where there is a cutaneous inflam-
matory process. For example, one patient presented with
conjunctival squamous cell carcinoma and another with
dermatofibroma-like lesions (Bielory et al., 2011; Forsyth
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et al., 2003). Leishmania parasites have also been detected
in tattoos and herpes zoster lesions (Lopez-Medrano
et al., 2007; Colebunders et al., 1999). To the best of our
knowledge, this is the first report of leishmaniasis present-
ing in an anal condyloma. It is unlikely that the parasites in
the condyloma represent the site of initial cutaneous infec-
tion. It is more likely that VL occurred as reactivated dis-
ease upon HIV-induced immunosuppression.
HIV and Leishmania species both infect cells of the mono-
cyte lineage. Previous investigations have shown these
micro-organisms to be synergistically pathogenic. HIV
co-infection of macrophages enhances Leishmania uptake
and intracellular replication. Furthermore, Leishmania
infection promotes the growth and survival of HIV-
infected monocytes, which stimulates HIV replication.
This results in higher rates of VL treatment failure, relapse
and case fatality compared with HIV-negative VL patients
(Jarvis & Lockwood, 2013). These findings highlight the
importance of thoroughly investigating all suspicious
signs found in an immunocompromised patient and main-
taining an awareness for the possibility of Leishmania
infection, especially in patients from endemic areas.
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